

ProPhase Labs to Release Fourth Quarter/Year-End Results on Tuesday, March 15th
DOYLESTOWN, PA--(Marketwire - March 9, 2011) - ProPhase Labs (
The conference call will be webcast live at [ http://us.meeting-stream.com/prophaselabsinc_031511 ] at 11:00 AM (EDT) on Tuesday, March 15, 2010.
Participants wishing to ask questions may access the live call by dialing (877) 217-6026 Conference ID # 50736554. A replay of the conference call will be available for 90 days on the Company web site at [ www.prophaselabs.com ].
About ProPhase Labs
ProPhase Labs is a diversified natural health medical science company. It is a leading marketer and manufacturer of the Cold-EEZE® family of lozenges clinically proven to significantly reduce the severity and duration of the common cold. Cold-EEZE customers include leading national retailers, chain food, drug and mass merchandise stores, wholesalers and distributors, as well as independent pharmacies. ProPhase Labs has several wholly owned subsidiaries including a manufacturing unit, which consists of an FDA registered facility to manufacture Cold-EEZE lozenges and fulfill other contract manufacturing opportunities. ProPhase also owns 50% of Phusion Laboratories, LLC ("Phusion"). Phusion licenses a revolutionary proprietary technology that has the potential to improve the delivery and/or efficacy of many active ingredients or compounds. Phusion will formulate and test products to exploit market opportunities within ProPhase's robust OTC distribution channels.
For more information visit us at [ www.ProPhaseLabs.com ].